Higher-intensity continuous renal-replacement therapy did not reduce mortality in critically ill patients with kidney injury

Parikh, Chirag R.; Belcher, Justin
February 2010
ACP Journal Club;2/16/2010, Vol. 152 Issue 2, p4
Academic Journal
The article presents information on studies on the relative effectiveness of higher-intensity and lower-intensity continual renal-replacement therapy (RRT) for reducing mortality. A study was conducted on 1508 critically ill patients 18 years of age who had acute kidney injury. It has been conclude that critically ill patients with acute kidney injury, higher- and lower-intensity renal-replacement therapy resulted in similar rates of mortality.


Related Articles

  • Fewer Kidney Rejections. Harrar, Sarí; Dawidowska, Kasia; Matus, Jordan; Rasich, Paula // Prevention;Feb2003, Vol. 55 Issue 2, p166 

    More than 50,000 Americans with failing kidneys are waiting for donor organs, because transplanted kidneys work better than dialysis machines. But many more have been ineligible for a transplant because they carry antibodies that raise the risk of rejection. Researchers at Johns Hopkins...

  • Impacto de la enfermedad renal avanzada del trasplantado renal y su vuelta a diálisis. Cubero, Juan José; Fresnedo, Gema Fernández; Luna, Enrique; Hernández-Gallego, Román; Arias, Manuel // Nefrologia;Feb2009 Supplement, Vol. 29 Issue S1, p3 

    Although long-term outcomes also improved, graft loss caused by chronic allograft nephropathy remains an important obstacle. This situation, together with the progressive increase in the number of renal transplant patients, means that the population of transplant patients readmitted to a...

  • Serum β2-microglobulin at discharge predicts mortality and graft loss following kidney transplantation. Astor, Brad C; Muth, Brenda; Kaufman, Dixon B; Pirsch, John D; Michael Hofmann, R; Djamali, Arjang // Kidney International;Oct2013, Vol. 84 Issue 4, p810 

    Serum β2-microglobulin (β2M), a novel marker of kidney function, predicts mortality and kidney failure in the general population, and its elevation following transplantation is a marker of acute rejection. The association between post-transplant serum β2M and outcomes following kidney...

  • The mortality risk with graft function has decreased among children receiving a first kidney transplant in the United States. Laskin, Benjamin L; Mitsnefes, Mark M; Dahhou, Mourad; Zhang, Xun; Foster, Bethany J // Kidney International;Mar2015, Vol. 87 Issue 3, p575 

    Mortality has decreased in children with end-stage kidney disease. Decreases in mortality during dialysis and improved graft survival contributed to this improvement. However, it is unknown whether rates of death with graft function have also improved. We measured this in first transplant...

  • Hypertension in Children After Renal Transplantation. Seeman, Tomáš // Current Hypertension Reviews;2007, Vol. 3 Issue 1, p59 

    Hypertension is a serious complication in children after renal transplantation, it is an important risk factor not only for graft loss but also for cardiovascular morbidity and mortality of transplanted patients. The etiology of posttransplant hypertension is multifactorial - pretransplant...

  • Rapamycin Inhibits Cystogenesis by Cystic Epithelial Cells Derived from Human Autosomal Dominant Polycystic Kidneys. Elberg, Gerard; Lewis, Teresa V.; Lijuan Chen; Turman, Martin A. // American Journal of Pharmacology & Toxicology;2006, Vol. 1 Issue 4, p79 

    Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common genetic disorders and carries a high health burden since it progresses to renal failure in half of the afflicted individuals by the 6th decade of life. Currently, there is no effective treatment to slow the...

  • Regression methods for gap time hazard functions of sequentially ordered multivariate failure time data. Schaubel, Douglas E.; Jianwen Cai // Biometrika;Jun2004, Vol. 91 Issue 2, p291 

    Sequentially ordered multivariate failure time data are often observed in biomedical studies and inter‐event, or gap, times are often of interest. Generally, standard hazard regression methods cannot be applied to the gap times because of identifiability issues and induced dependent...

  • COMPANY SPOTLIGHT -- Genzyme.  // PharmaWatch: Monthly Review;Jan2007, Vol. 6 Issue 1, p50 

    The article reports on the second clinical study conducted by Genzyme Corp. concerning a cancer treatment for leukemia patients called Clolar. The phase two will examine the safety and effectiveness of Clolar in previous untreated adult patients with acute myelogenous leukemia. Genzyme expects...

  • The effect of a first kidney transplant on a subsequent transplant outcome: An experimental and clinical study. Lair, David; Coupel, Stéphanie; Giral, Magali; Hourmant, Maryvonne; Karam, Georges; Usal, Claire; Bignon, Jean Denis; Sophie Brouard; Soulillou, Jean-Paul // Kidney International;Jun2005, Vol. 67 Issue 6, p2368 

    The effect of a first kidney transplant on a subsequent transplant outcome: An experimental and clinical study.Background.Second kidney transplantations have a roughly similar clinical outcome to first transplantations. Nevertheless, the effect of the presence of the first, nonfunctional...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics